US Patent Issued to SHANGHAI WD PHARMACEUTICAL on July 7 for "Pharmaceutical composition containing dabigatran etexilate and preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,049, issued on July 7, was assigned to SHANGHAI WD PHARMACEUTICAL Co. LTD (Shanghai).

"Pharmaceutical composition containing dabigatran etexilate and preparation method thereof" was invented by Liang Chang Dong (Shanghai), Shizhong Zhang (Shanghai), Yan Jiao (Shanghai), Danyong Zhang (Shanghai), Wenfang Zhao (Shanghai) and Jingmin Shi (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a pharmaceutical composition containing dabigatran etexilate and a preparation method thereof. The pharmaceutical composition comprises a pharmaceutically active ingredient, dabigatran etexilate and/or dabigatran etexilate mesylate, an amphiphilic pol...